Genetic heterogeneity in osteogenesis imperfecta.
D O Sillence, A Senn, D M Danks
https://pubmed.ncbi.nlm.nih.gov/458828Actively Recruiting
Led by University Hospital, Toulouse · Updated on 2026-05-08
30
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating the effects of a 6-month adapted physical activity program on the endurance of children and adolescents aged 7 to 18 with Osteogenesis Imperfecta (OI), a rare genetic condition causing fragile bones and muscle weakness. The study aims to see if this exercise program can improve maximum oxygen consumption (VO2 peak), endurance, and quality of life by addressing common symptoms such as chronic fatigue and decreased physical function. The intervention involves a personalized training program tailored to each participant's condition and abilities. Assessments will take place over two visits spaced six months apart at the Constitutional Bone Diseases unit. The adapted physical activity program will be shared with participants and their families via videoconference, with regular adjustments made every 15 days through phone calls by an APA coach to support ongoing participation. Participants will undergo evaluations including endurance testing, quality of life questionnaires, step counts, and weight measurements at the start and after six months. Researchers will monitor changes in maximum endurance capacity and other health indicators. The study provides ongoing support and reassessment to help maintain engagement and track progress throughout the six-month period.
CONDITIONS
Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants follow a personalized training program adapted to their condition and capacities, developed from their initial assessment.
2 visits spaced 6 months apart and phone calls every 15 days
Total: 2 locations
1
CHU Montpellier Hôpital Arnaud de Villeneuve
Montpellier, France
Not Yet Recruiting
2
CHU Toulouse
Toulouse, France
Actively Recruiting
T
Thomas EDOUARD, MD
M
Marjolaine WILLEMS, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
D O Sillence, A Senn, D M Danks
https://pubmed.ncbi.nlm.nih.gov/458828Vittoria Rossi, Brendan Lee, Ronit Marom
https://pubmed.ncbi.nlm.nih.gov/31693577Elena Monti, Monica Mottes, Paolo Fraschini...
https://pubmed.ncbi.nlm.nih.gov/20856683Heidi Arponen, Janna Waltimo-Sirén, Helena Valta...
https://pubmed.ncbi.nlm.nih.gov/29310646Arjan G J Harsevoort, Koert Gooijer, Fleur S van Dijk...
https://pubmed.ncbi.nlm.nih.gov/31900144